Volume 10, Issue 4 (winter 2014)                   Sci J Iran Blood Transfus Organ 2014, 10(4): 364-371 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nikoozad R, Mahzounieh M, Naghavi N. Genomic detection of parvovirus B19 in patients suffered from chronic anemia, leukemia/lymphoma in Isfahan, Iran. Sci J Iran Blood Transfus Organ 2014; 10 (4) :364-371
URL: http://bloodjournal.ir/article-1-828-en.html
Full-Text [PDF 267 kb]   (2399 Downloads)     |   Abstract (HTML)  (11496 Views)
Full-Text:   (5415 Views)
    References:
  1. Shen T, Huang Y, Qiao F, Li Z, Liu H. Detection of human parvovirus B19 nonstrutural protein DNA by nested-polymerase chain reaction in gravida serum and pregnant tissues. J Huazhong Univ Sci Technolog Med Sci 2006; 26(1): 123-6.
  2. Mahmoodian Shooshtari M, Sharifi Z. Detection of Human Parvovirus B19 Markers in Blood Samples of Donors. Iranian  Journal of Virology 2011; 5(2): 9-12.
  3. Kishore J, Sen M, Kumar A, Kumar A. A pilot study on parvovirus B19 infection in paediatric haematological malignancies. Indian J Med Res 2011; 133: 407-13.
  4. Mahmoodian Shooshtari M, Foroghi MN, Hamkar R. High Prevalence of Parvovirus B19 IgG Antibody among Hemophilia Patients in Center for Special Diseases, Shiraz, Iran. Iran J Publ Health 2005; 34(1): 51-4.
  5. Reinheimer C, Allwinn R, Doerr HW, Wittek M. Seroepidemiology of parvovirus B19 in the Frankfurt am Main area, Germany: evaluation of risk factors. Infection 2010; 38(5): 381-5.
  6. Us T, Ozune L, Kasifoglu N, Akgun Y. The investigation of parvovirus B19 Infection in patients with haematological disorders by Using PCR and ELISA techniques. Braz J Infect Dis 2007; 11(3): 327-30.
  7. Siritantikorn S, Kaewrawang S, Siritanaratkul N, Theamboonlers A, Poovorawan Y, Kantakamalakul W et al. The Prevalence and Persistence of  Human Parvovirus B19 Infection in Thalassemic Patients. Asian Pac J Allergy Immunol 2007; 25(2-3): 169-74.
  8. Servey JT, Reamy BV, Hodge J. Clinical presentations of parvovirus B19 infection. Am Fam Physician 2007; 75(3): 373-6.
  9. Heegaard ED, Petersen BL, Heilmann CJ, Hornsleth A. Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals. J Clin Microbiol 2002; 40(3): 933-6.
  10. Regaya F, Oussaief L, Bejaoui M, Karoui M, Zili M, Khelifa R. Parvovirus B19 infection in Tunisian patients with sickle-cell anemia and acute erythroblastopenia. BMC Infect Dis 2007; 7: 123.
  11. Young NS, Brown KE. Mechanisms of disease: Parvovirus B19. N Engl J Med 2004; 350(6): 586-97.
  12. Obeid OE. Molecular and serological assessment of parvovirus B19 infections among sickle cell anemia patients. J  Infect Dev Ctries 2011; 5(7): 535-9.
  13. Kuo SH, Lin LI, Chang CJ, Liu YR, Lin KS, Cheng AL. Increased risk of parvovirus B19 infection in young adult cancer patients receiving  multiple  courses
 
of chemotherapy. J Clin Microbiol 2002; 40(11): 3909-12.
  1. Ideguchi H, Ohno SH, Ishigatsubo Y. A case of pure red cell aplasia and systemic lupus erythematosus caused by human parvovirus B19 infection. Rheumatol Int 2007; 27(4): 411-4.
  2. Zerbini M, Musiani M, Gentilomi G, Venturoli S, Gallinella G, Morandi R. Comparative evaluation of virological and serological methods in prenatal diagnosis of parvovirus B19 fetal hydrops. J Clin Microbiol 1996; 34(3): 603-8.
  3. Wen JQ, Zhou N, Li D, Feng HL, Wang H. Study on clinical characteristics and follow-up visit of acquired aplastic anemia associated with parvovirus B19 infection. Indian J Pediatr 2012; 79(6): 741-6.
  4. Ayatollahi J, mellat A, Ayatollahi J, Hashemi A, Taghipoor zahir Sh, Ghasemi N. Application of PCR for diagnosis infectious diseases. Journal of Shahid Sadoughi University of Medical Sciences 2011; 18(6): 578-86. [Article in Farsi]
  5. Heegaard  ED, Myhre J, Hornsleth A, Gundestrup M, Boye H. Parvovirus B19 Infections In Patients With Chronic anemia. Haematologica 1997; 82(4): 402-5.
  6. Mishra B, Malhotra P, Ratho RK, Singh MP, Varma S, Varma N. Human parvovirus B19 in patients with aplastic anemia. Am J Hematol 2005; 79(2): 166-7.
  7. Gupta V, Saini I, Nath G. Prevalence of Parvovirus B19 Infection in Children with Aplastic Anemia. Indian Pediatr 2013; 50(5): 489-91.
  8. Mahmudi F, Mahmoodian Shooshtari M, Sharifi Z, Hosseinni M. Prevalence of parvovirus B19 in blood donors tested by ELISA and PCR. Sci J Iran Blood Transfus Organ 2009; 5(1): 47-52. [Article in Farsi]
  9. Qian XH, Zhang GC, Jiao XY, Zhang YJ, Cao YH, Xu DL, et al. Aplastic anaemia associated with parvovirus B19 infection. Arch Dis Child 2002; 87(5): 436-7.
  10. Bhattarakosol P, Pancharoen C, Kowitdamrong E, Thammaborvorn R, Mungmee V. Prevalence of parvovirus B19 infection in Thai young adults. Southeast Asian J Trop Med Public Health 2003; 34(3): 585-8.
  11. Doyle S, Kerr S, O'Keeffe G, O'Carroll D, Daly P, Kilty C. Detection of parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristic analysis. J Virol Methods 2000; 90(2): 143-52.
  12. Toan N, Song le H, Kremsner PG, Duy DN, Binh VQ, Duechting A , et al. Co-infection of human B19 in Vietnamese patients with hepatitis B virus infection. J  Hepatol 2006; 45(3): 361-9.
 



 
Original Article
 
 
 
 
Sci J Iran Blood Transfus Organ 2014; 10(4): 364-371
 
 

Genomic detection of parvovirus B19 in patients
suffered from chronic anemia, leukemia/lymphoma
in Isfahan, Iran
 
Nikoozad R.1, Mahzounieh M.R.2, Naghavi N.S.1
 
 
1Faculty of Biological Science, Islamic Azad University Falavarjan Branch, Falavarjan, Iran
2Zoonosis Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran
 
 
Abstract
Background and Objectives
Parvovirus B19 may cause a number of clinical illnesses including infectious erythem, arthropathy hydropes fetalis or congenital anemia, and transient aplastic crises. The virus is very infectious and is transmitted via respiratory tract, and blood transfusion. The aim of this study was to detect B19 virus in persons who suffer from blood disorders.
 
Materials and Methods
Parvovirus B19 infection was compared in patients suffering from blood disorders with healthy people in Isfahan, Iran. Sera were collected from 35 and 30 patients with the history of chronic anemia and lukemia/lymphoma. Thirty persons were considered as control group without any blood complications. DNAs of all sera were extracted and tested for presence of B19 DNA using semi-nested PCR.
 
Results
B19 DNA was detected in 15 samples (23.1%) out of 65 patient sera. The infection rate was 17.1% and 30% among benign and malignant blood disorder groups, respectively. None of healthy people showed positive results.
 
Conclusions 
Results are consistent with previous studies indicating that parvovirus B19 infection in high-risk individuals is higher including patients with hematologic disorders. Blood donor screening for parvovirus B19 in high risk patients is necessary and can effectively reduce the incidence and prevalence of B19 infection.
 
Key words: Parvovirus, Hematologic Diseases, PCR, Iraniseases, PCR, Isfahanic d, Iran.
 
 
 
 
 
 
Received:  6 Feb 2013
Accepted:18 Jun 2013
 
 
 
 

Correspondence: Nikoozad R., MSc of Microbiology. Faculty of Biological Science, Islamic Azad University Falavarjan Branch.
P.O.Box: 84515-155, Falavarjan, Iran. Tel: (+98311) 7420140; Fax: (+98311) 7420140
E-mail: R_nikoozad@yahoo.com
Type of Study: Research | Subject: Hematology
Published: 2013/12/21

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Scientific Journal of Iran Blood Transfus Organ

Designed & Developed by : Yektaweb